TCT-556 Exposure to Glucocorticoids Prior to Transcatheter Aortic Valve Replacement is Associated with Reduced Incidence of High-Degree AV block and Pacemaker

TCT-556 Exposure to Glucocorticoids Prior to Transcatheter Aortic Valve Replacement is Associated with Reduced Incidence of High-Degree AV block and Pacemaker

Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction block. Results Of the 167patients included, 16 (9.5%) were exposed to glucocorticoids prior to TAVR.No differences in age, STS score, pre-existing right...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B230-B230
Hauptverfasser: Oestreich, Brett, Adabag, Selcuk, Kelly, Rosemary, Helmer, Gregory, Raveendran, Ganesh, Yannopoulos, Demetris, Biring, Timinder, Garcia, Santiago
Format: Artikel
Sprache:eng
Schlagworte:
Aortic valve
Cardiology
Edema
Electrocardiography
Glucocorticoids
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tissue edema and inflammation, which occur at the device landing zone during valve deployment, may contribute to the pathophysiology of conduction block. Results Of the 167patients included, 16 (9.5%) were exposed to glucocorticoids prior to TAVR.No differences in age, STS score, pre-existing right bundle branch block or valve type were seen among patients exposed to glucocorticoids versus those who were unexposed (table).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.733